U.S. markets open in 9 hours 6 minutes

Invacare Corporation (IVC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
0.8000+0.0160 (+2.04%)
At close: 04:00PM EDT
0.8400 +0.04 (+5.00%)
After hours: 04:20PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.7840
Bid0.0000 x 3100
Ask0.0000 x 800
Day's Range0.7802 - 0.8200
52 Week Range0.7600 - 5.3600
Avg. Volume372,243
Market Cap29.279M
Beta (5Y Monthly)0.51
PE Ratio (TTM)N/A
EPS (TTM)-1.5920
Earnings DateOct 25, 2022 - Oct 31, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateApr 02, 2020
1y Target Est3.27
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for IVC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Invacare Corporation
    IVC: What does Argus have to say about IVC?INVACARE CORP has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    11 months agoArgus Research
View more
  • Business Wire

    Invacare Corporation Announces Additional Draw of Term Loans and Exchange of Existing Convertible Notes

    ELYRIA, Ohio, October 03, 2022--Invacare Corporation (NYSE:IVC) ("Invacare" or the "company") announced today the consummation of additional draws of an aggregate of $18,500,000 of term loans pursuant to its Credit Agreement with certain funds managed by Highbridge Capital Management LLC ("Highbridge"). Additional commitments of $19,500,000 remain available under the Amended Highbridge Loan Agreement, subject to the satisfaction of certain conditions set forth therein.

  • Business Wire

    Invacare Corporation Receives Notice of Noncompliance with NYSE Trading Share Price Listing Rule

    ELYRIA, Ohio, September 29, 2022--Invacare Corporation (NYSE: IVC) today announced that it received notice from the New York Stock Exchange (the "NYSE") that the company is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the company’s Common Shares was less than $1.00 per share over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the company’s Common Shares from the NYSE.

  • Business Wire

    Invacare Corporation Announces Executive Leadership Changes

    ELYRIA, Ohio, August 29, 2022--Invacare Corporation (NYSE: IVC) today announced changes to its senior management team and Board of Directors to advance its previously announced business transformation initiatives, address supply chain challenges, and strengthen its financial performance. Geoffrey P. Purtill, who had been serving as the company’s Senior Vice President and General Manager, EMEA and APAC, was named interim President and Chief Executive Officer, replacing Matthew E. Monaghan, who ha